Home > Pharmacy > Other > Volume-7 > Issue-6 > Regulatory Considerations for Personalized Medicine and Precision Therapeutics

Regulatory Considerations for Personalized Medicine and Precision Therapeutics

Call for Papers

Volume-8 | Issue-6

Last date : 27-Dec-2024

Best International Journal
Open Access | Peer Reviewed | Best International Journal | Indexing & IF | 24*7 Support | Dedicated Qualified Team | Rapid Publication Process | International Editor, Reviewer Board | Attractive User Interface with Easy Navigation

Journal Type : Open Access

First Update : Within 7 Days after submittion

Submit Paper Online

For Author

Research Area


Regulatory Considerations for Personalized Medicine and Precision Therapeutics


Mavya Padamati | Markad Monika Rangnath



Mavya Padamati | Markad Monika Rangnath "Regulatory Considerations for Personalized Medicine and Precision Therapeutics" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-7 | Issue-6, December 2023, pp.47-52, URL: https://www.ijtsrd.com/papers/ijtsrd60105.pdf

Personalized medicine and precision therapeutics are revolutionizing the healthcare landscape by tailoring medical treatments to individual patients based on their unique genetic, molecular, and clinical characteristics. This review article delves into the essential regulatory considerations that underpin the development and deployment of personalized medicine and precision therapeutics. It explores the regulatory agencies and frameworks governing this field, emphasizing the roles of entities such as the FDA and EMA. The article examines the challenges of ethical, legal, and social implications (ELSI), data privacy, and the delicate balance between innovation and safety in this evolving landscape. Key components of regulatory considerations, including biomarker development, companion diagnostics, clinical trial design, and post-market surveillance, are analyzed for their critical roles in ensuring the efficacy and safety of these novel treatments. The article concludes with an exploration of emerging technologies such as CRISPR and their regulatory implications, shedding light on potential future directions in this rapidly evolving field.

personalized medicine, precision therapeutics, regulatory considerations, FDA, EMA, biomarker development, companion diagnostics, clinical trial design, post-market surveillance, CRISPR, emerging technologies


IJTSRD60105
Volume-7 | Issue-6, December 2023
47-52
IJTSRD | www.ijtsrd.com | E-ISSN 2456-6470
Copyright © 2019 by author(s) and International Journal of Trend in Scientific Research and Development Journal. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (http://creativecommons.org/licenses/by/4.0)

International Journal of Trend in Scientific Research and Development - IJTSRD having online ISSN 2456-6470. IJTSRD is a leading Open Access, Peer-Reviewed International Journal which provides rapid publication of your research articles and aims to promote the theory and practice along with knowledge sharing between researchers, developers, engineers, students, and practitioners working in and around the world in many areas like Sciences, Technology, Innovation, Engineering, Agriculture, Management and many more and it is recommended by all Universities, review articles and short communications in all subjects. IJTSRD running an International Journal who are proving quality publication of peer reviewed and refereed international journals from diverse fields that emphasizes new research, development and their applications. IJTSRD provides an online access to exchange your research work, technical notes & surveying results among professionals throughout the world in e-journals. IJTSRD is a fastest growing and dynamic professional organization. The aim of this organization is to provide access not only to world class research resources, but through its professionals aim to bring in a significant transformation in the real of open access journals and online publishing.

Thomson Reuters
Google Scholer
Academia.edu

ResearchBib
Scribd.com
archive

PdfSR
issuu
Slideshare

WorldJournalAlerts
Twitter
Linkedin